Continuing Outcomes Relevant to Evista (CORE) Investigators. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study - Siris, E S; Harris, S T; Eastell, R (J Bone Miner Res, 2005)
Epub 2005 May 16 PMID: 16059623